Celanese Corporation Common Stock (CE) fair value

ACCE thesis

Celanese makes acetyls (acetic acid, vinyl acetate monomer, and acetate esters) and engineered materials such as POM engineering polymers and Micromax, a specialty product sold into automotive and electronics, along with a sizeable acetate tow business for cigarette filters. The acetyl chain is the structural core: it is one of the largest integrated positions in its markets, which gives it scale in a commodity-heavy chemicals sector. The near-term swing factor is the cyclical recovery in acetyl pricing and volumes, together with the deleveraging and portfolio pruning management has pursued after the 2024 dividend cut. Revenue growth of 8.7% and an operating margin of 11.1% suggest the top line is moving again, but the 21.4% gross margin and negative ROE of -22.3% show the balance sheet and returns are still under strain, and the 41/100 score reflects that. At a forward P/E of 7.2 the market is pricing in little recovery, so the question for a PM is whether margins can rebuild faster than the debt load shrinks; the name merits a deeper look if the next two quarters show acetyl spreads holding.